Cloherty and Stark's Manual of Neonatal Care.

Format:

Book

Author/Creator:

Hansen, Anne R.

Contributor:

Stark, Ann R.

Eichenwald, Eric C.

Martin, Camilla R.

Language:

English

Subjects (All):

Neonatology.

Intensive care nursing.

Physical Description:

1 online resource (2070 pages)

Edition:

9th ed.

Place of Publication:

Philadelphia : Wolters Kluwer Health, 2022.

Summary:

Cloherty and Stark's Manual of Neonatal Care, now in its ninth edition, is a comprehensive reference guide for healthcare professionals involved in neonatal intensive care. Edited by leading experts including Eric C. Eichenwald, Anne R. Hansen, Camilia R. Martin, and Ann R. Stark, this manual provides detailed insights into the diagnosis and treatment of newborn diseases. It includes contributions from a wide array of specialists in pediatrics and neonatology, offering evidence-based guidelines and practical advice for managing the complexities of neonatal care. The book is intended for use by medical practitioners, including pediatricians, neonatologists, and nurses, and serves as a critical resource for making informed medical decisions regarding newborns. It emphasizes the importance of individualized patient assessment and the need for healthcare professionals to consult various sources to ensure the best outcomes. The manual is essential for any healthcare facility that specializes in the care of newborns, providing up-to-date information and guidance on neonatal intensive care practices. Generated by AI.

Contents:

Intro

1 Fetal Assessment and Prenatal Diagnosis

I. GESTATIONAL AGE ASSESSMENT

II. PRENATAL DIAGNOSIS OF FETAL DISEASE

III. FETAL SIZE AND GROWTH-RATE ABNORMALITIES

IV. FUNCTIONAL MATURITY OF THE LUNGS

V. ASSESSMENT OF FETAL WELL-BEING

2 Maternal Diabetes Mellitus

I. CLASSIFICATION OF DIABETES IN PREGNANCY

II. EPIDEMIOLOGY

III. COMPLICATIONS

IV. PRECONCEPTION MANAGEMENT

V. ANTEPARTUM MANAGEMENT

VI. INTRAPARTUM AND POSTPARTUM MANAGEMENT

3 Preeclampsia and Related Hypertensive Conditions of Pregnancy

I. CATEGORIES OF PREGNANCY-ASSOCIATED HYPERTENSIVE DISORDERS

II. INCIDENCE AND EPIDEMIOLOGY

III. DIAGNOSIS

IV. COMPLICATIONS

V. CONSIDERATIONS IN MANAGEMENT

VI. CLINICAL MANAGEMENT OF GESTATIONAL HYPERTENSION AND PREECLAMPSIA WITHOUT SEVERE FEATURES

VII. MANAGEMENT OF PREECLAMPSIA WITH SEVERE FEATURES

VIII. MANAGEMENT OF ECLAMPSIA

IX. POSTPARTUM PREECLAMPSIA

X. RECURRENCE RISK

XI. LONG-TERM CARDIOVASCULAR RISK

XII. PROPOSED TREATMENTS

XIII. IMPLICATIONS FOR THE NEWBORN

4 Resuscitation in the Delivery Room

I. GENERAL PRINCIPLES

II. PREPARATION

III. DURING DELIVERY

IV. SPECIAL SITUATIONS

V. MONITORING RESUSCITATION

VI. POSTRESUSCITATIVE CARE

VII. WITHHOLDING OR DISCONTINUING RESUSCITATION

VIII. TEAMWORK DURING NEONATAL RESUSCITATION

5 Nonimmune Hydrops Fetalis

I. DEFINITION

II. INCIDENCE

III. ETIOLOGY

IV. PATHOPHYSIOLOGY

V. EVALUATION

VI. PRENATAL TREATMENT

VII. MATERNAL COMPLICATIONS OF FETAL HYDROPS

VIII. DELIVERY CONSIDERATIONS

IX. NEONATAL MANAGEMENT OF FETAL HYDROPS

6 Birth Trauma

I. BACKGROUND

II. TYPES OF BIRTH TRAUMA

7 The High-Risk Newborn: Anticipation, Evaluation, Management, and Outcome

I. HIGH-RISK NEWBORNS

II. GESTATIONAL AGE (GA) AND BIRTH WEIGHT CLASSIFICATION

III. PRETERM BIRTH.

IV. POSTTERM INFANTS

V. SGA

VI. LGA

8 Assessment of the Newborn History and Physical Examination of the Newborn

I. HISTORY

II. ROUTINE PHYSICAL EXAMINATION OF THE NEONATE

9 Care of the Well Newborn

I. ADMISSION TO THE NEWBORN NURSERY

II. TRANSITIONAL CARE

III. ROUTINE CARE

IV. ROUTINE MEDICATIONS

V. SCREENING

VI. ROUTINE ASSESSMENTS

VII. FAMILY AND SOCIAL ISSUES

VIII. FEEDINGS

IX. NEWBORN CIRCUMCISION

X. DISCHARGE PREPARATION

XI. FOLLOW-UP

10 Genetic Issues Presenting in the Nursery

IV. APPROACH TO THE INFANT WITH A CONGENITAL MALFORMATION OR OTHER SUSPECTED GENETIC DISORDER

11 Multiple Births

I. CLASSIFICATION

IV. DIAGNOSIS

V. PRENATAL SCREENING AND DIAGNOSIS

VI. MATERNAL COMPLICATIONS

VII. FETAL AND NEONATAL COMPLICATIONS

VIII. OUTCOMES

12 Maternal Substance Use, Infant Exposure, and Neonatal Opioid Withdrawal Syndrome

I. MATERNAL DRUG USE

II. DIAGNOSIS OF DRUG USE IN PREGNANCY

III. NONOPIOID SUBSTANCE EXPOSURE

IV. NEONATAL OPIOID WITHDRAWAL SYNDROME FOLLOWING OPIOID EXPOSURE IN PREGNANCY

V. BREASTFEEDING OF SUBSTANCE-EXPOSED INFANTS

VI. DISCHARGE

VII. LONG-TERM OUTCOMES

13 Initial Care of the Extremely Low Birth Weight Infant

I. INTRODUCTION

II. PRENATAL CONSIDERATIONS

III. DELIVERY ROOM CARE

IV. CARE IN THE INTENSIVE CARE UNIT

V. SUMMARY

14 Developmentally Supportive Care

II. ASSESSMENT

III. GOALS OF DEVELOPMENTAL SUPPORT

IV. DEVELOPMENTALLY SUPPORTIVE ENVIRONMENT

V. DEVELOPMENTALLY SUPPORTIVE CARE PRACTICES

VI. PAIN AND STRESS

VII. PARENT SUPPORT/EDUCATION

15 Temperature Control

II. TEMPERATURE MAINTENANCE

III. MECHANISMS OF HEAT LOSS

IV. THERMONEUTRAL ENVIRONMENT.

V. MANAGEMENT TO PREVENT HEAT LOSS

VI. HAZARDS OF TEMPERATURE CONTROL METHODS

16 Follow-up Care of Very Preterm and Very Low Birth Weight Infants

II. MEDICAL CARE ISSUES

III. NEURODEVELOPMENTAL OUTCOMES

IV. HIGH-RISK INFANT FOLLOW-UP PROGRAMS

17 Neonatal Transport

II. INDICATIONS

III. ORGANIZATION OF TRANSPORT SERVICES

IV. REFERRING HOSPITAL RESPONSIBILITIES

V. TRANSPORT TEAM RESPONSIBILITIES

VI. MEDICAL MANAGEMENT BEFORE TRANSPORT

VII. MEDICAL MANAGEMENT DURING RETURN TRANSPORT

VIII. ARRIVAL AT THE NEONATAL INTENSIVE CARE UNIT

IX. SPECIFIC CONDITIONS AND MANAGEMENT

X. PHYSIOLOGIC CONSIDERATIONS OF AIR TRANSPORTS

XI. SIMULATION IN TRANSPORT MEDICINE

18 Neonatal Intensive Care Unit Discharge Planning

II. INFANT'S DISCHARGE READINESS

III. PARENT'S DISCHARGE PREPARATION

19 Decision Making and Ethical Dilemmas

II. DEVELOPING A PROCESS FOR ETHICAL DECISION MAKING

III. MATERNAL'FETAL ETHICS

IV. EXTREMELY PREMATURE INFANTS

V. THE DECISION TO REDIRECT LIFE-SUSTAINING TREATMENT TO COMFORT MEASURES

20 Management of Neonatal End-of-Life Care and Bereavement Follow-up

II. FAMILY-CENTERED END-OF-LIFE CARE PRINCIPLES AND DOMAINS

III. COORDINATION OF CARE

IV. BEREAVEMENT FOLLOW-UP

21 Nutrition

II. GROWTH

III. NUTRIENT RECOMMENDATIONS FOR PRETERM INFANTS

IV. SPECIAL CONSIDERATIONS

V. NUTRITIONAL CONSIDERATIONS IN DISCHARGE PLANNING

ACKNOWLEDGMENTS

22 Breastfeeding and Maternal Medications

I. RATIONALE FOR BREASTFEEDING

II. RECOMMENDATIONS ON BREASTFEEDING FOR HEALTHY TERM INFANTS INCLUDE THE FOLLOWING GENERAL PRINCIPLES (CENTERS FOR DISEASE CONTROL AND PREVENTION, AMERICAN ACADEMY OF PEDIATRICS).

III. MANAGEMENT AND SUPPORT ARE NEEDED FOR SUCCESSFUL BREASTFEEDING

IV. MANAGEMENT OF BREASTFEEDING PROBLEMS

V. SPECIAL SITUATIONS

VI. CARE AND HANDLING OF EXPRESSED BREAST MILK

VII. CONTRAINDICATIONS AND CONDITIONS NOT CONTRAINDICATED TO BREASTFEEDING

VIII. MATERNAL MEDICATIONS AND BREASTFEEDING

IX. DETERMINATION OF DRUG SAFETY DURING BREASTFEEDING

X. RESOURCES

23 Fluid and Electrolyte Management

I. DISTRIBUTION OF BODY WATER

II. ASSESSMENT OF FLUID AND ELECTROLYTE STATUS

III. MANAGEMENT OF FLUIDS AND ELECTROLYTES

IV. APPROACH TO DISORDERS OF NA AND WATER BALANCE

V. OLIGURIA

VI. METABOLIC ACID-BASE DISORDERS

VII. DISORDERS OF K BALANCE

VIII. COMMON CLINICAL SITUATIONS

24 Hypoglycemia and Hyperglycemia

I. HYPOGLYCEMIA

II. HYPERGLYCEMIA

25 Abnormalities of Serum Calcium and Magnesium

I. HYPOCALCEMIA

II. HYPERCALCEMIA

III. DISORDERS OF MAGNESIUM: HYPOMAGNESEMIA AND HYPERMAGNESEMIA

26 Neonatal Hyperbilirubinemia

II. BILIRUBIN METABOLISM

III. NONPATHOLOGIC (BENIGN) HYPERBILIRUBINEMIA

IV. SIGNIFICANT HYPERBILIRUBINEMIA

V. PREVENTION OF HYPERBILIRUBINEMIA IN HEALTHY TERM AND LATE-PRETERM INFANTS

VI. EVALUATION OF INFANTS WITH HYPERBILIRUBINEMIA

VII. FAMILY AND CAREGIVER EDUCATION

VIII. CLINICAL MANAGEMENT

IX. BILIRUBIN NEUROTOXICITY

X. NEONATAL CHOLESTASIS

27 Necrotizing Enterocolitis

II. DIAGNOSIS

III. MANAGEMENT

IV. PROGNOSIS

28 Neonatal Kidney Conditions

I. RENAL EMBRYOGENESIS AND FUNCTIONAL DEVELOPMENT

II. CLINICAL ASSESSMENT OF THE KIDNEYS AND URINARY TRACT

III. COMMON CLINICAL KIDNEY PROBLEMS IN NEONATES

29 Mechanical Ventilation

II. NONINVASIVE VENTILATORY SUPPORT

III. INVASIVE MECHANICAL VENTILATORY SUPPORT

IV. INDICATIONS FOR RESPIRATORY SUPPORT.

V. HOW VENTILATOR CHANGES AFFECT BLOOD GASES

VI. DISEASE STATES

VII. ADJUNCTS TO MECHANICAL VENTILATION

VIII. COMPLICATIONS AND SEQUELAE

30 Blood Gas and Pulmonary Function Monitoring

II. OXYGEN USE AND MONITORING

III. ASSESSMENT OF PULMONARY VENTILATION

IV. PULMONARY GRAPHICS MONITORING

31 Apnea

II. PATHOGENESIS

III. MONITORING AND EVALUATION

IV. TREATMENT

V. DISCHARGE CONSIDERATIONS

32 Transient Tachypnea of the Newborn

II. PATHOPHYSIOLOGY

III. EPIDEMIOLOGY

IV. CLINICAL PRESENTATION

V. DIFFERENTIAL DIAGNOSIS

VI. EVALUATION

VII. MANAGEMENT

VIII. COMPLICATIONS

IX. PROGNOSIS

33 Respiratory Distress Syndrome

III. PREVENTION

IV. MANAGEMENT

34 Bronchopulmonary Dysplasia

I. BRONCHOPULMONARY DYSPLASIA (BPD)

III. PATHOGENESIS

IV. THE CLINICAL PRESENTATION

V. EFFORTS TO PREVENT BPD AND MINIMIZE LUNG INJURY

VI. MANAGEMENT OF INFANTS WITH ESTABLISHED BPD

VII. IDENTIFICATION AND TREATMENT OF COMPLICATIONS ASSOCIATED WITH BPD

VIII. DISCHARGE PLANNING

IX. OUTPATIENT THERAPY

X. CHILD AND ADULT OUTCOMES OF BPD

35 Meconium Aspiration

III. PREVENTION OF MECONIUM ASPIRATION SYNDROME

IV. MANAGEMENT OF INFANTS DELIVERED THROUGH MECONIUM-STAINED FLUID

V. MANAGEMENT OF MECONIUM ASPIRATION SYNDROME

36 Persistent Pulmonary Hypertension of the Newborn

II. PHYSIOLOGY AND PATHOGENESIS

III. EPIDEMIOLOGIC ASSOCIATIONS AND RISK FACTORS

IV. CLASSIFICATION

V. DIAGNOSIS

VI. MANAGEMENT

VII. POSTNEONATAL OUTCOMES AMONG INFANTS WITH PPHN

37 Pulmonary Hemorrhage

IV. PREDISPOSING FACTORS

V. CLINICAL PRESENTATION.

VI. EVALUATION.

Notes:

Description based on publisher supplied metadata and other sources.

Part of the metadata in this record was created by AI, based on the text of the resource.

OCLC:

1353787678